Agenturet er blevet anmodet om at gennemføre Fællesskabets telematikstrategi for lægemiddellovgivning.
At the same time the EMEA will need to keep its focus on management of its core business of the evaluation of new applications and the supervision of an increasing stock of authorised medicines.